Amylyx Pharmaceuticals, INC. (AMLX) SEC Filings — 2025

Filings

• Amylyx Shifts Focus Amidst Zero Revenue, Bolsters Cash by $147M — 10-Q · Nov 6, 2025
• Amylyx Pharmaceuticals Files 8-K — 8-K · Sep 10, 2025
• Amylyx Pharmaceuticals Files 8-K — 8-K · Aug 27, 2025
• Amylyx's Net Loss Widens to $100.2M Despite 25% Revenue Growth — 10-Q · Aug 7, 2025
• Amylyx Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2025
• Amylyx Pharmaceuticals Files 8-K on Security Holder Votes — 8-K · Jun 5, 2025
• Amylyx Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Amylyx Pharma DEF 14A: Executive Compensation Details — DEF 14A · Apr 24, 2025
• Amylyx Pharmaceuticals Files 2024 10-K — 10-K · Mar 4, 2025
• Amylyx Pharmaceuticals Files 8-K — 8-K · Jan 10, 2025